Siddika Demir

Keiretsu Forum Türkiye, Türkiyede faaliyet gösteren lisanslı bir melek yatırımcı ağıdır. Teknoloji, tüketim malları, internet, sağlık, enerji, yapay zeka, robotik, gayrimenkul gibi yüksek büyüme potansiyeli olan sektörlere 100den fazla melek yatırımcısı ile yatırım yapmaktadır. Kurulduğundan bugüne 100’e yakın start-up’a toplamda 150 milyon TL’den fazla yaptığı yatırım ile Türkiye’nin en büyük ve en güçlü melek yatırımcı ağı olmayı başarmıştır.

Keiretsu Forum is a global angel investment community of accredited private equity angel investors, venture capitalists and corporate/institutional investors. Keiretsu Forum was founded in San Francisco, California in 2000 and now has with 53 chapters across 4 continents. We launched the London chapter in 2023 and are proud to serve the United Kingdom angel investment community. Our worldwide network of capital, resources and deal flow enable investment in high-quality, diverse start-ups and investment opportunities. Keiretsu Forum and Keiretsu Capital (the exclusive worldwide fund partner of Keiretsu Forum) are ranked as the most active venture investors in the USA. For more information, please visit our website at https://www.keiretsuforum.com/ and read about why we were the most active angel investment group in 2022: https://www.investorcapitalexpo.com/news/3rljb9u9e4v1i071ecriry20bwdjl9. "Keiretsu"​ definition Keiretsu is a Japanese term describing a group of affiliated corporations with broad power and reach. Keiretsu Forum is described as a conglomeration of individuals or small companies that are organised around private equity funding for mutual benefit. Keiretsu Forum believes that through a holistic approach that includes interlocking relationships with partners and key resources, they can offer an association that produces the highest quality deal-flow and investment opportunities.

Keiretsu Forum Türkiye, Türkiyede faaliyet gösteren lisanslı bir melek yatırımcı ağıdır. Teknoloji, tüketim malları, internet, sağlık, enerji, yapay zeka, robotik, gayrimenkul gibi yüksek büyüme potansiyeli olan sektörlere 100den fazla melek yatırımcısı ile yatırım yapmaktadır. Kurulduğundan bugüne 100’e yakın start-up’a toplamda 150 milyon TL’den fazla yaptığı yatırım ile Türkiye’nin en büyük ve en güçlü melek yatırımcı ağı olmayı başarmıştır.

European Women on Boards (EWOB) is a European non-profit association based in Brussels. Since its foundation in 2013, EWOB has been committed to advancing gender equality in decision-making roles across Europe. The organisation actively supports senior women leaders aspiring to C-Level and board positions by providing professional development programs, international networking opportunities, and monthly events to its community, counting over 500 members today. EWOB also champions change across Europe through research and advocacy in collaboration with local partners and European institutions.

At med.essence GmbH, we aim to change healthcare workflows by automating time consuming and error-prone management tasks and empowering medical professionals by automation and smart suggestions using cloud native AI technology.

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible. Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management. Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims to improve patient access to medical innovations by working with all relevant stakeholders. Thirty medicines developed by Roche are included in the World Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry ten years in a row by the Dow Jones Sustainability Indices (DJSI). For more information, please visit https://careers.roche.com Read our community guidelines here: https://www.roche.com/some-guidelines.htm #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalisedHealthcare #GreatPlaceToWork #Innovation